@theinfographicsshow
1 post audited · 6 claims analysed
Science evidence grade
Based on 6 claims across 1 audit
5
Supported
83%
1
Overstated
17%
0
Misleading
0%
0
No Evidence
0%
Share this evidence grade
Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards
What @theinfographicsshow claims actually are
We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).
Evidence-based
83%
5 claims
Claims that align with published human or clinical evidence at the stated strength.
Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.
Factually incorrect
0%
0 claims
Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.
Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.
Grey / overstated
17%
1 claim
Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.
Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.
Evidence mix
Share of audited claims in each bucket
Verdict detail
Grey splits into overstated (wrong certainty) vs no published support
Claims over time
Stacked by bucket as audits land — plus the running evidence grade
Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).
Audit history(1 post)
“Peptides EXPLAINED”
The claims are substantially supported by existing preclinical research, established peptide pharmacology, and active human clinical trials. Peptide-mediated cellular signaling (particularly GH secretagogues and tissue-repair peptides) is well-documented; BPC-157 and ipamorelin/CJC-1295 show consistent evidence in animal models and are actively being tested in human trials. The main limitation across all claims is that definitive human efficacy data remains incomplete—most evidence is preclinical (animal studies, in-vitro mechanisms) or from early-phase trials still recruiting. No claims are contradicted by the literature; however, claims framed as 'complete' or 'unprecedented' healing should be contextualized as preclinical-stage findings pending human confirmation.
Audit another post from @theinfographicsshow
Paste their social post link to add a new audit